See more : 1st Federal Savings Bank of SC, Inc. (FSGB) Income Statement Analysis – Financial Results
Complete financial analysis of Itamar Medical Ltd. (ITMR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Itamar Medical Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Coronado Global Resources Inc. (CODQL) Income Statement Analysis – Financial Results
- Investeringsforeningen Danske Invest – USA – Akkumulerende KL (DKIUSAIAKKDKKH.CO) Income Statement Analysis – Financial Results
- BCI Minerals Limited (BIRNF) Income Statement Analysis – Financial Results
- Telephone and Data Systems, Inc. (TDS) Income Statement Analysis – Financial Results
- MRV Engenharia e Participações S.A. (MRVE3.SA) Income Statement Analysis – Financial Results
Itamar Medical Ltd. (ITMR)
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.03M | 31.26M | 24.19M | 20.70M | 18.44M | 16.81M | 16.39M | 13.34M | 13.43M |
| Cost of Revenue | 12.32M | 6.98M | 5.73M | 5.00M | 4.98M | 4.40M | 4.80M | 4.26M | 3.80M |
| Gross Profit | 28.71M | 24.27M | 18.46M | 15.70M | 13.46M | 12.41M | 11.59M | 9.08M | 9.62M |
| Gross Profit Ratio | 69.97% | 77.66% | 76.33% | 75.84% | 73.00% | 73.81% | 70.72% | 68.07% | 71.68% |
| Research & Development | 6.00M | 4.52M | 3.64M | 4.13M | 3.23M | 2.83M | 2.02M | 1.89M | 1.69M |
| General & Administrative | 8.50M | 6.35M | 5.25M | 5.28M | 5.36M | 4.30M | 4.63M | 4.88M | 2.55M |
| Selling & Marketing | 24.55M | 18.29M | 12.70M | 12.14M | 14.04M | 10.68M | 8.44M | 7.40M | 5.69M |
| SG&A | 33.05M | 24.65M | 17.95M | 17.42M | 19.40M | 14.98M | 13.07M | 12.28M | 8.23M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 849.00K | 52.00K | 113.00K | 117.00K | 217.00K |
| Operating Expenses | 39.06M | 29.17M | 21.58M | 21.55M | 23.47M | 17.87M | 15.20M | 14.29M | 10.14M |
| Cost & Expenses | 51.38M | 36.15M | 27.31M | 26.55M | 28.45M | 22.27M | 20.00M | 18.54M | 13.94M |
| Interest Income | 713.00K | 454.00K | 93.00K | 1.39M | 547.00K | 176.00K | -571.00K | 714.00K | 121.00K |
| Interest Expense | 562.00K | 284.00K | 794.00K | 4.43M | 4.61M | 4.19M | 2.51M | 4.83M | 2.12M |
| Depreciation & Amortization | 1.82M | 1.29M | 481.00K | 509.00K | 434.00K | 367.00K | 324.00K | 400.00K | 330.00K |
| EBITDA | -8.43M | -3.66M | -330.00K | -280.00K | -9.23M | 2.44M | -313.00K | -7.73M | 2.76M |
| EBITDA Ratio | -20.55% | -11.71% | -1.36% | -1.35% | -50.04% | 14.53% | -1.91% | -57.95% | 20.57% |
| Operating Income | -10.34M | -4.89M | -3.12M | -5.85M | -10.01M | -5.46M | -3.61M | -5.21M | -515.00K |
| Operating Income Ratio | -25.21% | -15.66% | -12.90% | -28.25% | -54.30% | -32.48% | -22.02% | -39.04% | -3.84% |
| Total Other Income/Expenses | -468.00K | -337.00K | 1.52M | 632.00K | -4.26M | 3.35M | 458.00K | -7.76M | 831.00K |
| Income Before Tax | -10.81M | -5.23M | -1.61M | -5.22M | -14.27M | -2.11M | -3.15M | -12.96M | 316.00K |
| Income Before Tax Ratio | -26.35% | -16.73% | -6.64% | -25.20% | -77.40% | -12.57% | -19.23% | -97.20% | 2.35% |
| Income Tax Expense | 127.00K | 37.00K | 124.00K | 85.00K | 131.00K | 135.00K | 124.00K | -44.00K | -201.00K |
| Net Income | -10.94M | -5.27M | -1.73M | -5.30M | -14.40M | -2.25M | -3.28M | -12.92M | 517.00K |
| Net Income Ratio | -26.66% | -16.85% | -7.15% | -25.61% | -78.11% | -13.37% | -19.99% | -96.87% | 3.85% |
| EPS | -0.79 | -0.46 | -0.17 | -0.60 | -1.65 | -0.35 | -0.56 | -2.82 | 0.03 |
| EPS Diluted | -0.79 | -0.46 | -0.17 | -0.52 | -1.65 | -0.29 | -0.46 | -2.82 | 0.03 |
| Weighted Avg Shares Out | 13.85M | 11.54M | 10.13M | 8.80M | 8.75M | 6.39M | 5.83M | 4.58M | 16.42M |
| Weighted Avg Shares Out (Dil) | 13.85M | 11.54M | 10.13M | 10.13M | 8.75M | 7.73M | 7.15M | 4.58M | 16.42M |
Itamar Medical to Participate in the Piper 32nd Annual Virtual Healthcare Conference
CAESAREA, Israel, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology and digital health company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of...
Itamar Medical Ltd. (ITMR) CEO Gilad Glick on Q3 2020 Results - Earnings Call Transcript
Itamar Medical Ltd. (ITMR) CEO Gilad Glick on Q3 2020 Results - Earnings Call Transcript
Itamar Medical Announces Preliminary Results from Two Large Claims Database Studies Demonstrating Significant Health Economic Benefits of Effective Sleep Apnea Management for Cardiovascular Patients
Initial findings show potential for material short-term annual savings of up to $5,000 per cardiovascular patient when treated for sleep apnea Initial findings show potential for material short-term annual savings of up to $5,000 per cardiovascular patient when treated for...
Itamar Medical Reports Record Third Quarter 2020 Revenues
- Third Quarter Revenues Increase 36 % to $ 11.0 Million -
Itamar Medical to Report Third Quarter Financial Results and Host Conference Call on Tuesday, November 17, 2020
CAESAREA, Israel, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders,...
Brokerages Expect Itamar Medical Ltd. (NASDAQ:ITMR) Will Post Earnings of -$0.19 Per Share
Analysts predict that Itamar Medical Ltd. (NASDAQ:ITMR) will report earnings of ($0.19) per share for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Itamar Medical’s earnings, with the highest EPS estimate coming in at...
Zacks Investment Research Downgrades Itamar Medical (NASDAQ:ITMR) to Hold
Itamar Medical (NASDAQ:ITMR) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Itamar Medical Ltd is a medical technology company. It focuses on the...
Itamar Medical (NASDAQ:ITMR) Raised to “Buy” at Zacks Investment Research
Itamar Medical (NASDAQ:ITMR) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday, Zacks.com reports. The firm currently has a $21.00 price objective on the stock. Zacks Investment...
Itamar Medical (ITMR) Received its Third Buy in a Row
After Piper Sandler and Cowen & Co. gave Itamar Medical (NASDAQ: ITMR) a Buy rating last month, the company received another Buy, this time from H.C.
H.C. Wainwright Reiterates a Buy Rating on Itamar Medical (ITMR)
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Itamar Medical (ITMR) today and set a price target of $21.00. The company's shares closed
Source: https://incomestatements.info
Category: Stock Reports